Name | 5-(2-fluoropyridin-4-yl)-2-phenylmethoxy-N-pyridin-3-ylbenzamide |
---|---|
Synonyms |
Benzamide, 5-(2-fluoro-4-pyridinyl)-2-(phenylmethoxy)-N-3-pyridinyl-
SMANT hydrochloride UNII-Q641JSF42X GSK2578215A 2-(Benzyloxy)-5-(2-fluoro-4-pyridinyl)-N-(3-pyridinyl)benzamide |
Description | GSK2578215A is a potent and highly selective LRRK2 inhibitor; exhibits IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant.IC50 value: ~10 nM(wt-LRRK2; LRRK2 G2019S) [1]Target: LRRK2 inhibitorGSK2578215A exhibits exceptionally high selectivity for LRRK2 across the kinome, substantially inhibits Ser910 and Ser935 phosphorylation of both wild-type LRRK2 and G2019S mutant at a concentration of 0.3–1.0 μM in cells and in mouse spleen and kidney, but not in brain, following intraperitoneal injection of 100 mg/kg [1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 556.1±50.0 °C at 760 mmHg |
Molecular Formula | C24H18FN3O2 |
Molecular Weight | 399.417 |
Flash Point | 290.1±30.1 °C |
Exact Mass | 399.138306 |
PSA | 67.60000 |
LogP | 3.40 |
Appearance | white to beige |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.651 |
Storage condition | 2-8°C |
Water Solubility | DMSO: soluble15mg/mL, clear |
RIDADR | NONH for all modes of transport |
---|